Dongguan, China

Zheng Gu

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Zheng Gu - Innovator in Pharmaceutical Chemistry

Introduction

Zheng Gu is a prominent inventor based in Dongguan, China, known for his significant contributions to pharmaceutical chemistry. He holds a total of 9 patents, showcasing his innovative approach to drug development and treatment solutions.

Latest Patents

His latest patents include "Glucopyranosyl derivatives and their uses," which focuses on a glucopyranosyl derivative as a sodium-dependent glucose transporters1 (SGLT1) inhibitor. This invention is particularly relevant for the treatment of diabetes and related diseases. Another notable patent is for an "Isoquinolinone compound for inhibiting SSAO/VAP-1," which serves as an inhibitor of semicarbazide-sensitive oxidase and vascular adhesion protein-1. This compound is aimed at preventing and treating inflammation and diabetes-related conditions, including non-alcoholic fatty liver diseases.

Career Highlights

Zheng Gu has worked with notable companies such as Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. His work in these organizations has been instrumental in advancing pharmaceutical research and development.

Collaborations

Throughout his career, Zheng has collaborated with esteemed colleagues, including Wuyong Wu and Panpan Kang. These partnerships have fostered a collaborative environment that enhances innovation and the development of effective pharmaceutical solutions.

Conclusion

Zheng Gu's

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…